What is artemether 80 mg used for?
Pharmaceutical Product Monograph: Artemether Injection (80 mg/mL)
In the pharmaceutical industry, Artemether is a lipid-soluble methyl ether derivative of artemisinin. As a pharmacist and manufacturer, I view this molecule as a “Fast-Acting Schizonticide”—it is technically designed to provide a rapid “knockdown” of the malaria parasite in the bloodstream, especially when the patient is unable to take oral medication.
At your WHO-GMP facility in Mumbai, Artemether 80 mg is a critical “Anti-Malarial” SKU. It is primarily exported to Zone IVb regions (Sub-Saharan Africa and Southeast Asia) where Plasmodium falciparum resistance to older drugs like Chloroquine is high.
Therapeutic Profile: Primary Indications
Artemether 80 mg injection is indicated for the treatment of severe malaria caused by P. falciparum in both adults and children.
| Indication | Clinical Context | Technical Rationale |
| Severe Malaria | Hospitalized Patients | Used when the patient is vomiting, unconscious, or experiencing respiratory distress. |
| Cerebral Malaria | Neurological Crisis | Rapidly reduces parasite biomass to prevent permanent brain damage or death. |
| Multi-Drug Resistance | Treatment Failure | Effective against strains of malaria that have developed resistance to Chloroquine and Quinine. |
Mechanism: Endoperoxide Bridge Activation
Artemether works through a unique biochemical “explosion” inside the parasite:
Heme Interaction: The parasite digests human hemoglobin, releasing “free heme” (which is toxic to the parasite).
Free Radical Generation: The Endoperoxide bridge in the Artemether molecule reacts with the iron in the heme.
Molecular Destruction: This reaction creates unstable free radicals that chemically attack and “shred” the parasite’s proteins and membranes.
Parasite Clearance: Technically, Artemether has the fastest parasite clearance rate of any anti-malarial class, often reducing the parasite count by 10,000-fold within two life cycles.
The Pharmacist’s “Technical Warning”
The “Oily” Route: As a pharmacist, I must emphasize that Artemether 80 mg is an Oily Injection. It is strictly for Deep Intramuscular (IM) use only. It must NEVER be given intravenously (IV), as the oil carrier can cause a fatal embolism.
The “ACT” Transition: Once the patient is conscious and can tolerate food/drink (usually after 24–48 hours), they should technically be switched to a full course of an ACT (Artemisinin-based Combination Therapy) tablet to prevent the recurrence of the infection.
QT Prolongation: While safer than Quinine, high doses can occasionally affect heart rhythm. Use with caution in patients already taking other drugs that affect the QT interval.
First Trimester Caution: In pregnant women, Artemether is generally avoided in the first trimester unless it is a life-saving necessity and no other options are available.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Stability in Oil” USP: On your digital marketplace, highlight your Validated Sterilization Process for oily vehicles. Since Artemether is dissolved in tea-seed oil or arachis oil, achieving perfect clarity and sterility without degrading the active ingredient is a technical hallmark of your WHO-GMP compliance.
Targeting the “Global Fund”: For international tenders, emphasize that your 80 mg/mL strength is the standard therapeutic dose for adults, making it an ideal candidate for large-scale NGO and government procurement in malaria-endemic zones.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Artemether 80 mg/mL and 40 mg/mL (pediatric) injections to support your firm’s registration in international B2B markets.